These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
440 related items for PubMed ID: 9726235
1. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Surmely JF, Guenat E, Philippe J, Dussoix P, Schneiter P, Temler E, Vaxillaire M, Froguel P, Jéquier E, Tappy L. Diabetes; 1998 Sep; 47(9):1459-63. PubMed ID: 9726235 [Abstract] [Full Text] [Related]
2. Counterregulatory responses to hypoglycemia in patients with maturity-onset diabetes of the young caused by HNF-1alpha gene mutations (MODY3). Guenat E, Seematter G, Philippe J, Temler E, Jéquier E, Tappy L. Eur J Endocrinol; 2001 Jan; 144(1):45-9. PubMed ID: 11174836 [Abstract] [Full Text] [Related]
3. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations. Vaxillaire M, Pueyo ME, Clément K, Fiet J, Timsit J, Philippe J, Robert JJ, Tappy L, Froguel P, Velho G. Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964 [Abstract] [Full Text] [Related]
4. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations. Brackenridge A, Pearson ER, Shojaee-Moradie F, Hattersley AT, Russell-Jones D, Umpleby AM. Diabetes; 2006 Feb; 55(2):405-11. PubMed ID: 16443774 [Abstract] [Full Text] [Related]
5. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Hansen T, Eiberg H, Rouard M, Vaxillaire M, Møller AM, Rasmussen SK, Fridberg M, Urhammer SA, Holst JJ, Almind K, Echwald SM, Hansen L, Bell GI, Pedersen O. Diabetes; 1997 Apr; 46(4):726-30. PubMed ID: 9075819 [Abstract] [Full Text] [Related]
6. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Froguel P, Hattersley AT. Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165 [Abstract] [Full Text] [Related]
7. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families. Costa A, Bescós M, Velho G, Chêvre J, Vidal J, Sesmilo G, Bellanné-Chantelot C, Froguel P, Casamitjana R, Rivera-Fillat F, Gomis R, Conget I. Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480 [Abstract] [Full Text] [Related]
8. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H. Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980 [Abstract] [Full Text] [Related]
9. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3). Boileau P, Wolfrum C, Shih DQ, Yang TA, Wolkoff AW, Stoffel M. Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773 [Abstract] [Full Text] [Related]
10. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ. J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471 [Abstract] [Full Text] [Related]
11. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. Richter S, Shih DQ, Pearson ER, Wolfrum C, Fajans SS, Hattersley AT, Stoffel M. Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861 [Abstract] [Full Text] [Related]
12. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers. Sagen JV, Pearson ER, Johansen A, Spyer G, Søvik O, Pedersen O, Njølstad PR, Hattersley AT, Hansen T. Diabet Med; 2005 Apr; 22(4):406-9. PubMed ID: 15787664 [Abstract] [Full Text] [Related]
13. Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes. Doria A, Yang Y, Malecki M, Scotti S, Dreyfus J, O'Keeffe C, Orban T, Warram JH, Krolewski AS. Diabetes Care; 1999 Feb; 22(2):253-61. PubMed ID: 10333942 [Abstract] [Full Text] [Related]
16. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene. Menzel R, Kaisaki PJ, Rjasanowski I, Heinke P, Kerner W, Menzel S. Diabet Med; 1998 Oct; 15(10):816-20. PubMed ID: 9796880 [Abstract] [Full Text] [Related]